Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biodetection

    RFI – Rapid Diagnosis of Infectious Diseases in Austere Environments

    By Global Biodefense StaffMay 10, 2013
    Share
    Facebook LinkedIn Reddit Email

    U.S. Army Medical Research and Materiel Command (USAMRMC) is conducting market research to assess the availability and technical maturity of technologies for rapid diagnosis of infectious diseases in environments with limited infrastructure support.

    Prior to determining an acquisition strategy, USAMRMC will use this Request for Information (RFI) to assess the current state of available technologies and gauge industry interest and commercialization outlook for further development of candidates for the US market.

    Prioritized diseases of interest impacting military mission readiness include: dengue, leptospirosis, malaria, meningococcal meningitis and noroviral gastroenteritis. Estimated annual purchase quantities are 5,000 assays for each target.

    Specifically, the USAMRMC is interested in determining:

    Candidate diagnostic products, either in the development pipeline or currently marketed in the US or in foreign markets that can be used to diagnose the priority pathogens
    Current technology status of each candidate
    FDA clearance status and timelines
    Available data on device sensitivity, specificity, external controls, power requirements, weight, footprint, time to result, user complexity and storage
    Level of support interested industry sources would require from the DoD in terms of technical and scientific expertise, clinical sites, and research and development funding

    USAMRMC also requests industry feedback on strategies by which candidate assays can be combined, kitted, or otherwise optimized to reduce logistical burden and provide cost-savings over time.

    Further details are available under Solicitation Number: W81XWH13RFIID. The response deadline is May 21, 2013.

    Dengue POC Diagnostics RFI Ruggedized
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleStudy Reveals Insight on Bacteria Biofilm Formation
    Next Article Biodefense Headlines – May 12, 2013

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.